To confirm the interaction between CD2BP2‐DT and YBX1 in breast cancer cells, we conducted biotin‐labeled RNA pull‐down and RNA immunoprecipitation (RIP) assays (Figure 3E,F). This evidence concerns the gene YBX1 and breast carcinoma.